LINC00473
Putative transcriptional regulator encoded by LINC00473
Also known as: CF176_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LINC00473 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
186 residues, UniProt reviewed canonical sequence.
>A8K010|LINC00473
1 MELSAAAGRR RQAPWREFTG RHRTERSQER GSTPRKERSM GSRQPRKRER EPRDCTPTCT
61 NAASVSRSGA RRAPGCAGRC ITMKNCARAW RELSERACCF QAVPPSNMKQ SWLIFLDTTL
121 CSAWLLASSC PRLYAPLISF HCMCFNTVLL FPRLFGPTLS AKIQFNTDLS LRAIAWKCTK
181 DTTTYCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LINC00473 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LINC00473 as an antibody target. Whether an autoantibody or antibody against LINC00473 could matter depends on whether native LINC00473 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LINC00473 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LINC00473 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...